Moreover, blocking β2-AR signaling led to an increased mitochondrial mass and spare respiratory capacity of propranolol-treated tumor-bearing mice by blocking the expression of checkpoint inhibitors on T cells [67]. Here, ADRB2 is linked to neoplasm.